12 Ott 2023
Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO)
Visualizza Documento
29 Set 2023
Definitive chemoradiation in vulvar squamous cell carcinoma: outcome and toxicity from an observational multicenter Italian study on vulvar cancer (OLDLADY 1.1)
Visualizza Documento
24 Mag 2023
“Survey sulle Conoscenze e Atteggiamenti relativi all’Utilizzo della Radioterapia Stereotassica nella Gestione del Tumore ovarico oligometastatico/persistente/ricorrente (MPR-OC) in Trattamento con PARP-Inibitori” – deadline 15-07-2023
Lettera di invito alla compilazione Link per la Compilazione della Survey
EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC UTERINE CANCER (MITO-RT2/RAD STUDY): A LARGE, REAL-WORLD STUDY IN COLLABORATION WITH AIRO GYN, MITO and MaNGO Groups
Visualizza Documento
12 Nov 2022
Observational multicenter Italian study on vulvar cancer adjuvant radiotherapy (OLDLADY 1.2): a cooperation among AIRO Gyn, MITO and MaNGO groups
Visualizza Documento
8 Giu 2022
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups
Visualizza Documento
3 Feb 2022
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/ RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups
Visualizza Documento
